Extractive colorimetric method for the determination of dothiepin hydrochloride and risperidone in pure and in dosage forms

Three rapid, simple, reproducible and sensitive extractive colorimetric methods (A--C) for assaying dothiepin hydrochloride (I) and risperidone (II) in bulk sample and in dosage forms were investigated. Methods A and B are based on the formation of an ion pair complexes with methyl orange (A) and orange G (B), whereas method C depends on ternary complex formation between cobalt thiocyanate and the studied drug I or II. The optimum reaction conditions were investigated and it was observed the calibration curves resulting from the measurements of absorbance concentration relations of the extracted complexes were linear over the concentration range 0.1--12 microg ml(-1) for method A, 0.5--11 mug ml(-1) for method B, and 3.2--80 microg ml(-1) for method C with a relative standard deviation (RSD) of 1.17 and 1.28 for drug I and II, respectively. The molar absorptivity, Sandell sensitivity, Ringbom optimum concentration ranges, and detection and quantification limits for all complexes were calculated and evaluated at maximum wavelengths of 423, 498, and 625 nm, using methods A, B, and C, respectively. The interference from excipients commonly present in dosage forms and common degradation products was studied. The proposed methods are highly specific for the determination of drugs I and II, in their dosage forms applying the standard additions technique without any interference from common excipients. The proposed methods have been compared statistically to the reference methods and found to be simple, accurate (t-test) and reproducible (F-value).     

Spectrophotometric determination of pipazethate HCl, dextromethorphan HBr and drotaverine HCl in their pharmaceutical preparations

A simple, accurate and highly sensitive spectrophotometric method is proposed for the rapid determination of pipazethate hydrochloride, dextromethorphan hydrobromide and drotaverine hydrochloride using chromotrope 2B (C2B) and chromotrope 2R (C2R). The method consists of extracting the formed ion-associates into chloroform in the case of pipazethate HCl and dextromethorphan HBr or into methylene chloride in the case of drotaverine HCl. The ion-associates exhibit absorption maxima at 528, 540 and 532 nm with C2B and at 526, 517 and 522 nm with C2R for pipazethate HCl, dextromethorphan HBr and drotaverine HCl, respectively. The calibration curves resulting from the measurements of absorbance-concentration relations (at the optimum reaction conditions) of the extracted ion-pairs are linear over the concentration range 4.36-52.32 microg mL(-1) for pipazethate, 3.7-48.15 microg mL(-1) for dextromethorphan and 4.34-60.76 microg mL(-1) for drotaverine, respectively. The effect of acidity, reagent concentration, time, solvent and stoichiometric ratio of the ion-associates were estimated. The molar absorptivity and Sandell sensitivity of the reaction products were calculated. Statistical treatment of the results reflects that the procedure is precise, accurate and easily applied for the determination of the drugs under investigation in pure form and in their pharmaceutical preparations.     

Quantitation of ranitidine in pharmaceuticals by titrimetry and spectrophotometry using potassium dichromate as the oxidimetric reagent

Four new methods are described for the determination of ranitidine hydrochloride (RNH) in bulk drug and in formulations employing titrimetric and spectrophotometric techniques and using potassium dichromate as the oxidimetric reagent. In titrimetry (method A), RNH is treated with a measured excess of dichromate in acid medium, and the unreacted oxidant is back titrated with iron(II) ammonium sulfate. The three spectrophotometric methods are also based on the oxidation of RNH by a known excess of dichromate under acidic conditions followed by the determination of surplus oxidant by three different reaction schemes. In one procedure (method B), the residual dichromate is treated with diphenylcarbazide and the absorbance measured at 540 nm. Calculated amount of iron(II) is added to residual dichromate and the resulting iron(III) is complexed with thiocyanate and measured at 470 nm (method C). Method D involves reduction of unreacted dichromate by a calculated amount of iron(II) and estimation of residual iron(II) as its orthophenanthroline complex after raising the pH, and measuring the absorbance at 510 nm. In all the methods, the amount of dichromate reacted corresponds to the drug content. The experimental conditions are optimized. The titrimetric procedure is applicable over 5–10 mg range. In spectrophotometric methods, Beer’s law is obeyed in the ranges 5–50, 5–80, and 10–100 µg ml^?1 for method B, method C, and method D, respectively. The methods were validated for accuracy, precision and recovery. The proposed methods were applied to the analysis of RNH in the tablet and the injection forms, and the results were in agreement with those obtained by the reference method.     

Spectrophotometric methods for the determination of anti-emetic drugs in bulk and in pharmaceutical preparations.

Four rapid, simple, reproducible and sensitive methods (A-D) for assaying domperidone (I) and metoclopramide (II) in a bulk sample and in dosage forms were investigated. The first and second methods, A and B, are based on the oxidation of I and/or II by Fe3+ in the presence of o-phenanthroline (o-phen) or bipyridyl (bipy). The formation of tris-complex upon reactions with Fe3+-o-phen and/or Fe3+-bipy mixture in an acetate buffer solution of the optimum pH-values was demonstrated. Methods C and D involve the addition of excess Ce4+ and the determination of unreacted oxidant by a decrease of the red color of chromotrope 2R (C2R) at a suitable lambda(max) of 528 nm for method C, or a decrease in the orange pink color of Rhodamine 6G (Rh6G) at a suitable lambda(max) value of 525 nm for method D. A regression analysis of Beer-Lambert plots showed a good correlation in the concentration range of 0.2-5.8 microg ml(-1). The apparent molar absorptivity, Sandell sensitivity, detection and quantification limits were calculated. For a more accurate analysis, the Ringbom optimum concentration ranges are 0.35-5.6 microg ml(-1). The developed methods were successfully applied to the determination of domperidone and metoclopramide in bulk and pharmaceutical preparations without any interference from common excipients.     

Quantitative analysis of rabeprazole sodium in commercial dosage forms by spectrophotometry

The main aim of this work is to develop and validate two spectrophotometric methods for the quantitative analysis of rabeprazole sodium in commercial dosage forms. Method A is based on the reaction of drug with 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) in the presence of ammonium cerium(IV) nitrate in acetic acid medium at room temperature to form red-brown product which absorbs maximally at 470 nm. Method B utilizes the reaction of rabeprazole sodium with 1-chloro-2,4-dinitrobenzene (CDNB) in dimethyl sulfoxide (DMSO) at 45+/-1 degrees C to form yellow colored Meisenheimer complex. The colored complex has a characteristic band peaking at 420 nm. Under the optimized reaction conditions, proposed methods are validated as per ICH guidelines. Beer's law is obeyed in the concentration ranges of 14-140 and 7.5-165 microg ml(-1) with linear regression equations of A=6.041 x 10(-4)+1.07 x 10(-2)C and A=1.020 x 10(-3)+5.0 x 10(-3)C for methods A and B, respectively. The limits of detection for methods A and B are 1.38 and 0.75 microg ml(-1), respectively. Both methods have been applied successfully for the estimation of rabeprazole sodium in commercial dosage forms. The results are compared with the reference UV spectrophotometric method.     

Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form,in dosage forms and in the presence of its oxidative degradates

Three simple, accurate and sensitive colorimetric methods (A, B and C) for the determination of ranitidine HCl (RHCl) in bulk sample, in dosage forms and in the presence of its oxidative degradates are described. The first method A is based on the oxidation of the drug by N-bromosuccinimide (NBS) and determination of the unreacted NBS by measurement of the decrease in absorbance of amaranth dye (AM) at a suitable lambda(max)=520 nm. The methods B and C involve the addition of excess Ce(4+) and determination of the unreacted oxidant by decrease the red color of chromotrope 2R (C2R) at a suitable lambda(max)=528 nm for method B or decrease the orange pink color of rhodamine 6G (Rh6G) at a suitable lambda(max)=526 nm for method C. Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges 0.2-3.6, 0.1-2.8 and 0.1-2.6 microg ml(-1) for methods A, B and C, respectively. The apparent molar absorptivity. Sandell sensitivity, detection and quantitation limits were calculated. For more accurate results, Ringbom optimum concentration ranges were 0.3-3.4, 0.2-2.6 and 0.2-2.4 microg ml(-1) for methods A, B and C, respectively. Analyzing pure and dosage forms containing RHCl tested the validity of the proposed methods. The relative standard deviations were 相似文献   

Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations

Four simple and sensitive methods for the assay of omeprazole (OMZ) were developed. These methods are based on the formation of colored species by treating OMZ with 3-methyl-2-benzothiazolinone hydrazone (MBTH) following oxidation with ferric chloride (method A) or m-aminophenol following oxidation with chloramine-T (CAT) (method B) or Folin-Ciocalteau reagent (FC) (method D), or by oxidizing OMZ with excess N-bromosuccinimide (NBS) and determining the consumed NBS with a decrease in color intensity of Celestine blue (CB) (method C). All variables have been optimized. Regression analysis of Beer's plots showed good correlation in the concentration range of 1.0-10, 2.0-32, 0.4-2.4 and 0.8-10 mug ml(-1) for methods A, B, C and D, respectively. No interference was observed for formulation additives and the validity of each method was tested by analysing capsules containing OMZ. Recoveries were 98.7-100.1%.     

Comparison of calibration methods in quantitative diffuse reflectance infrared spectroscopy

Four different calibration methods were used for quantitative analysis of quartz and calcite in atmospheric aerosols by diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS): (A) conventional calibration with one measurement on each standard (single calibration); (B) calibration with an internal standard; (C) calibration with parallel (n = 4) measurements on each standard (multiple calibration); (D) multiple calibration followed by reference reflectance correction. The accuracy and the precision of the methods were compared and it was found that by using method D the reliability of the conventional pellet preparation transmission technique can be achieved.     

Spectrophotometric Methods for the Determination of Nelfinavir Mesylate

Three visual spectrophotometric methods are described for the assaying of nelfinavir mesylate (NEL) in either bulk form or dosage forms. Methods A-C are based on the oxidation of NEL with an excess of oxidant (N-bromosuccinimide (NBS) in methods A&B or chloramine-T (CAT) in method C) in acidic medium. The unreacted oxidant is then estimated colorimetrically using an oxidisable dye (Celistine blue (CB) in method A or Gallocyanine (GC) in method C) or p-N-methyl aminophenol sulphate (PMAP)-sulphanilamide (SA) reagent (in method B). These methods obey Beer's law and give reproducible results. Recoveries range from 99.3–100.5%.     

Assay of cisapride in pharmaceutical formulations by visible spectrophotometry

Three spectrophotometric methods (A-C) for the assay of cisapride (CPD) in pure and dosage forms are described. Method A is based on the oxidative coupling reaction of CPD with 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) in the presence of ferric chloride to form a coloured species (_max; 565 nm.) Method B is based on the oxidation of CPD with Fe (III) and subsequent chelation of Fe(II) to form a coloured complex with 1,10-phenanthroline (_max: 520 nm). Method C is based on the formation of a coloured charge-transfer complex between CPD and chloranilic acid (_max; 555 nm). Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges 2.0–32.0, 0.4–6.4 and 25.0–450.0 g/ml for methods A,B and C, respectively. The validity of the proposed methods was tested by analysing pharmaceutical dosage forms containing CPD and the relative standard deviations were within 1.0%     

Spectrophotometric methods for the determination of prazosin hydrochloride in tablets

Four simple and sensitive methods for the assay of prazosin hydrochloride (PRH) are developed. These methods are based on the formation of coloured species by treating it either with excess N-bromosuccinimide (NBS) and determining the unconsumed NBS with p-N-methyl aminophenol sulphate (metol)-sulphanilamide (SA) reagent (method A, lambda(max) 520 nm): with 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) in the presence of eerie ammonium sulphate (CAS) (method B, lambda(max) 620 nm) or with acidic dyes such as orange-II (O-II) (method C, lambda(max) 490 nm) and alizarin violet 3B (AV-3B) (method D, lambda(max) 570 nm) under the specified experimental conditions. Regression analysis of Beer's law plot showed good correlation in the concentration range of 1.0-10.0, 2.5-25.0, 1.0-17.5 and 2.5-30.0 mug ml for methods A, B, C and D respectively.     

New colorimetric methods for the determination of trazodone HCl,famotidine, and diltiazem HCl in their pharmaceutical dosage forms

Two sensitive and simple spectrophotometric methods are developed for the determination of trazodone HCl, famotidine, and diltiazem HCl in pure and pharmaceutical preparations. The methods are based on the oxidation of the cited drugs with iron(III) in acidic medium. The liberated iron(II) reacts with 1,10-phenanthroline (method A) and the ferroin complex is colorimetrically measured at 510 nm against reagent blank. Method B is based on the reaction of the liberated Fe(II) with 2,2-bipyridyl to form a stable colored complex with lambda(max )at 520 nm. Optimization of the experimental conditions was described. Beer's law was obeyed in the concentration range of 1-5, 2-12, and 12-32 microg mL(-1) for trazodone, famotidine, and diltiazem with method A, and 1-10 and 8-16 microg mL(-1) for trazodone and famotidine with method B. The apparent molar absorptivity for method A is 1.06x10(5), 2.9x10(4), 1.2x10(4) and for method B is 9.4x10(4 )and 1.6x10(4), respectively. The suggested procedures could be used for the determination of trazodone, famotidine, and diltiazem, both in pure and dosage forms without interference from common excipients.     

Spectrophotometric determination of azathioprine in pharmaceutical formulations

Four simple and sensitive visible spectrophotometric methods (A–D) have been described for the assay of azathioprine (ATP) either in pure form or in pharmaceutical formulations. Methods A and B are based on the oxidation of ATP with excess N-bromosuccinimide (NBS) or chloramine-T (CAT) and determining the consumed NBS or CAT with a decrease in colour intensity of celestine blue (CB) (method A) or gallocyanine (GC) (method B), respectively. Methods C and D are based on the diazotisation of reduced azathioprine (RATP) with excess nitrous acid and estimating either the consumed nitrous acid (HNO₂) with cresyl fast violet acetate (CFVA) (method C) or by coupling reaction of the diazonium salt formed with N-1-naphthyl ethylene diamine dihydrochloride (NED) (method D). All of the variables have been optimized and the reactions presented. The concentration measurements are reproducible within a relative standard deviation of 1.0%. Recoveries are 99.2–100.3%.     

Extractive spectrophotometric determination of some fluoroquinolone derivatives in pure and dosage forms

Two simple and sensitive extractive spectrophotometric methods for the determination of some fluoroquinolone derivatives (norfloxacin, NRF; ciprofloxacin, CPF; ofloxacin, OFL; and enrofloxacin, ERF) with Supracene Violet 3B (SV 3B, method A) and tropaeolin 000 (TP 000, method B) are described. The methods are based on the formation of ion-association complexes of fluoroquinolones with these dyes, which are extracted into chloroform and have absorption maxima at 575 nm (SV 3B) and 485 nm (TP 000). The methods obey Beer's law and the precision and accuracy of the methods were checked by UV reference methods. The detection limits were 5.0 mug/ml for NRF and 2.5 mug/ml for CPF in method A and 2.5 mug/ml for OFL and ERF in methods A and B.     

Spectrophotometric assay of cephalosporins in pharmaceutical products,using chromotrope 2B and chromotrope 2R

A simple, rapid and sensitive Spectrophotometric method is proposed for the determination of cephadroxil (I), cephalexin (II) and cephradine (III). The method is based on ion-pair complex formation between these derivatives and Chromotrope 2B (C2B) or Chromotrope 2R (C2R), to give a highly coloured radical anion. The coloured products are quantified spectrophotometrically at 542 and 564 nm for C2B and C2R, respectively. The optimization of the experimental conditions is described. The method has been used for the determination of 0.4–15, 0.4–14 and 0.4–18 g/ml of drugs I, II and III, respectively. The accuracy of the method is indicated by the excellent recovery (100.0±1.7%) and the precision is supported by the low relative standard deviations 1.5%. The sensitivity of the method is discussed and the results are compared with the official method. The interference from common degradation products and excipients was also studied. The proposed method was applied successfully to the determination of the different cephalosporins in dosage forms, with good precision and accuracy. The results were compared with those given by the official B.P. 1993 method.     

Caveats for poly(methimazolyl)borate chemistry: the novel inorganic heterocycles [H2C(mt)2BR2]Cl (mt = methimazolyl; BR2 = BH2, BH(mt), 9-BBN)

Whilst frequently used for reactions of poly(methimazolyl)borates, dichloromethane is not an innocent solvent, but rather slowly forms heterocyclic salts [H(2)C(mt)(2)BR(2)]Cl, three examples of which (BR(2) = BH(2), BH(mt), 9-borabicyclononyl) have been structurally characterised to confirm the unprecedented B(NCS)(2)C connectivity.     

Iodometric determination of milligram and microgram amounts of levocetirizine in pharmaceuticals

Four simple, selective and sensitive methods are described for the determination of levocetirizine dihydrochloride (LCT) in bulk drug and in tablets. The methods exploit the well-known analytical reaction between iodide and iodate in the presence of acid solution. Iodide present is oxidized by iodate in an amount equivalent to the HCl present in LCT to iodine and the liberated iodine is determined by four different procedures which inturn quantify LCT at varying detection range and sensitiveness. Two direct titrimetric procedures involve titration of iodine by thiosulphate either towards starch end point (method A) or potentiometrically (method B). Both the methods have a reaction stiochiometry of 1: 1 (LCT: liberated iodine) and have quantification ranges of 2–20 mg LCT for method A and method B. The liberated iodine is also measured spectrophotometrically at 350 nm (method C) or the iodine-starch complex measured at 570 nm (method D). In both the methods, the absorbance is found to be linearly dependent on the concentration of iodine which in turn is related to LCT concentration. The calibration curves are linear over 5–40 and 1.25–12.5 mg mL^?1 LCT for method C and method D, respectively. The calculated molar absorptivity and Sandel sensitivity values are 1.0 × 10⁴ L mol^?1 cm^?1 and 0.0435 mg cm^?2, respectively for method C, and their respective values for method D are 2.9 × 10⁴ L mol^?1 cm^?1 and 0.0156 mg cm^?2. The intra-day and inter-day accuracy and precision studies were carried according to the ICH guidelines. The method was successfully applied to the analysis of two brands of tablets LCT. The accuracy was also checked by placebo blank and synthetic mixture analyses besides recovery study via standard addition procedure.     

多层螺旋CT诊断甲状腺癌中的辐射和对比剂剂量选择

本文对多层螺旋CT（MSCT）诊断甲状腺癌中的辐射和对比剂剂量选择进行了分析。选取2016年12月～2018年12月本院行MSCT检查的甲状腺癌、甲状腺良性结节患者各200例,依据随机数字表分为A组、B组、C组、D组,每组50例,A组参数为对比剂1.2 mL/kg、120 kV、180 mA,B组为对比剂1.0 mL/kg、120 kV、180 mA,C组为对比剂1.2 mL/kg、100 kV、100 mA,D组为对比剂1.0 mL/kg、100 kV、100 mA。结果显示,A组和B组CT容积剂量指数（CTDIvol）、剂量长度乘积（DLP）、有效辐射剂量（ED）明显低于C组和D组,A组和B组甲状腺CT值、背景信号、背景噪声明显高于C组和D组,差异有统计学意义（P<0.05）,A组、B组、C组、D组信噪比（SNR）、对比信噪比（CNR）、图像质量评分比较,差异无统计学意义（P>0.05）;A组、B组、C组、D组诊断甲状腺癌的敏感度、特异度、准确度比较,差异无统计学意义（P>0.05）。本文证实,对于MSCT诊断甲状腺癌中的辐射和对比剂剂量,选择1.0 mL/kg、100 kV、100 mA可在不严重影响图像质量及检查结果下有效减少患者的CT辐射,值得临床推广。     

Simultaneous determination of caffeine, 8-chlorotheophylline, and chlorphenoxamine hydrochloride in ternary mixtures by ratio-spectra zero-crossing first-derivative spectrophotometric and chemometric methods

A ratio-spectra zero-crossing first-derivative spectrophotometric method and 2 chemometric methods have been used for the simultaneous determination of ternary mixtures of caffeine (A), 8-chlorotheophylline (B), and chlorphenoxamine hydrochloride (C) in bulk powder and dosage forms. In the ratio-spectra zero-crossing first-derivative spectrophotometric technique (1DD), calibration curves were linear in the range of 4-20 microg/mL for A, B, and C (r = 0.9992, 0.9994, and 0.9976, respectively). The measurements were carried out at 212, 209.2, and 231.4 nm for A, B, and C, respectively. The detection limits for A, B, and C were calculated to be 0.24, 0.34, and 0.13 microg/mL, and the percentage recoveries were 99.1 +/- 0.89, 100.1 +/- 0.95, and 100.1 +/- 1.0, respectively. Two chemometric methods, namely, the partial least-squares (PLS) model and the principal component regression (PCR) model, were also used for the simultaneous determination of the 3 drugs in the ternary mixture. A training set consisting of 15 mixtures containing different ratios of A, B, and C was used. The concentration used for the construction of the PLS and PCR models varied between 4 and 25 microg/mL for each drug. These models were used after their validation for the prediction of the concentrations of A, B, and C in mixtures. The detection limits for A, B, and C were calculated to be 0.13, 0.15, and 0.14 microg/mL, respectively, and the percent recoveries were found to be 99.8 micro 0.96, 99.9 micro 0.94, and 99.9 micro 1.18, respectively, for both methods. The 3 proposed procedures are rapid, simple, sensitive, and accurate. No preliminary separation steps or resolution equations are required; thus, they can be applied to the simultaneous determination of the 3 drugs in commercial tablets and suppositories or in quality-control laboratories.     

华萝摩的化学成分

从萝摩科植物华萝摩(Metaplexis hemsleyana Oliv.)的根中分离到四个新甾体去氧糖甙, 分别命名为hemoside A(1), hemosideB(2), hemoside C(3)和hemoside D(4)。经光谱分析及化学反应鉴定其结构依次为: 12, 20-O-二苯甲酰肉珊瑚苷元3-O-β-D-磁麻吡喃糖苷; 12, 20-O-二苯甲酰肉珊瑚苷元3-O-β-D-黄夹吡喃糖基(1→4)-β-D-夹竹桃吡喃糖基(1→4)-β-D-磁麻吡喃糖苷; 12-O-乙酰-20-O-苯甲酰肉珊瑚苷元3-O-β-D-黄夹吡喃糖基(1→4)-β-D-夹竹桃吡喃糖基(1→4)-β-D-磁麻吡喃糖苷; 吉马苷元3-O-β-D-黄夹吡喃糖基(1→4)-β-D-夹竹桃吡喃糖基(1→4)-β-D-磁麻吡喃糖苷。